Sanofi SA 1Q 2015-- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) first-quarter results, based on a poll of nine analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released April 30.

=== 
                                Business  Business 
                     Net   Sales    Oper.      net Business 
1st Quarter        sales  Lantus  Income    income      EPS 
AVERAGE            8,490   1,612   2,222     1,579     1.20 
Prev. Year         7,842   1,448   2,145     1,547     1.17 
+/- in %            +8.3     +11    +3.6      +2.0     +2.9 
 
MEDIAN             8,474   1,614   2,214     1,567     1.20 
Maximum            8,704   1,641   2,396     1,691     1.29 
Minimum            8,230   1,572   2,082     1,488     1.14 
Amount                 9       7       9         9        8 
 
Barclays           8,690   1,605   2,296     1,615     1.23 
Bernstein          8,704   1,639   2,396     1,691     1.29 
BofA-Merrill Lynch 8,474   1,572   2,153     1,512     1.16 
Deutsche Bank      8,409   1,598   2,214     1,565     1.20 
Exane BNP Paribas  8,286   1,641   2,082     1,488     1.14 
Independent Res.   8,230      --   2,230     1,600       -- 
Jefferies          8,666   1,615   2,235     1,611     1.22 
Morgan Stanley     8,471      --   2,191     1,567     1.20 
UBS                8,476   1,614   2,201     1,558     1.19 
 
 
                Target price  Rating               DPS 2015 
AVERAGE                99.25  positive 2  AVERAGE      2.92 
Prev. Quarter          80.29  neutral  7  Prev. Year   2.85 
+/- in %                 +24  negative 0  +/- in %     +2.3 
 
MEDIAN                100.50              MEDIAN       2.95 
Maximum               107.00              Maximum      3.05 
Minimum                89.00              Minimum      2.63 
Amount                     8              Amount          6 
 
Barclays               93.00  Equalweight              3.02 
Bernstein             107.00  Outperform               2.63 
BofA-Merrill Lynch    105.00  Buy                      2.90 
Deutsche Bank          94.00  Hold                     3.00 
Exane BNP Paribas      89.00  Neutral                    -- 
Independent Res.      105.00  Hold                     2.90 
Jefferies             101.00  Hold                       -- 
Morgan Stanley            --  Equalweight                -- 
UBS                   100.00  Neutral                  3.05 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires